Cargando…
Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial
BACKGROUND: Patients with Prader-Willi syndrome (PWS) have a cognitive impairment. Growth hormone (GH) treatment during childhood improves cognitive functioning, while cognition deteriorates in GH-untreated children with PWS. Cessation of GH treatment at attainment of adult height (AH) might deterio...
Autores principales: | Kuppens, R. J., Mahabier, E. F., Bakker, N. E., Siemensma, E. P. C., Donze, S. H., Hokken-Koelega, A. C. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112648/ https://www.ncbi.nlm.nih.gov/pubmed/27852283 http://dx.doi.org/10.1186/s13023-016-0535-7 |
Ejemplares similares
-
Prevalence of growth hormone (GH) deficiency in previously GH‐treated young adults with Prader‐Willi syndrome
por: Donze, Stephany H., et al.
Publicado: (2019) -
Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition
por: Damen, Layla, et al.
Publicado: (2020) -
Twenty Years of GH Treatment in Adults with Prader-Willi Syndrome
por: Sjöström, Anna, et al.
Publicado: (2021) -
Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome
por: Giménez-Palop, Olga, et al.
Publicado: (2021) -
Evidence for Accelerated Biological Aging in Young Adults with Prader–Willi Syndrome
por: Donze, Stephany H, et al.
Publicado: (2019)